Equifax Inc. CEO Mark W. Begor completed a significant stock transaction on July 24, 2026, involving the sale of approximately 37,791 shares and the acquisition of stock options, according to a regulatory filing. The transaction was executed under a pre-established trading plan adopted in …
ProLogium Holding Inc. and Translational Development Acquisition Corp. announced on July 28, 2026, that the companies have secured $50 million in committed primary capital investment from existing ProLogium shareholders to support their proposed business combination. The investment, made at ProLogium's previously announced pre-money valuation …
Entravision Communications Corp. (NYSE: EVC) disclosed that Mark Boelke, the company's Chief Financial Officer and Chief Operating Officer, acquired 5,236 shares of Class A Common Stock on July 25, 2026, through a stock withholding transaction to satisfy tax obligations tied to the vesting of …
Carl Russo, a director and 10% owner of Calix Inc., disclosed the sale of 75,000 shares of common stock on July 27, 2026, at a weighted average price of $36.1974 per share, according to a regulatory filing. The transaction was executed pursuant to a …
Garth N. Weber, Senior Vice President of Brand and Marketing at Duluth Holdings Inc., completed a stock transaction involving 422 shares of Class B Common Stock on July 25, 2026. The disclosure, filed with the Securities and Exchange Commission on July 28, 2026, shows …
Thomas A. Richlovsky, a director of United Community Banks Inc., transferred 2,526 shares of the company's common stock to a family trust on July 24, 2026. The transfer was disclosed in a regulatory filing on July 28, 2026, and reflects a shift in the …
Jennifer M. Bazante, a director of United Community Banks Inc. (NYSE: UCB), transferred 2,526 shares of the company's common stock to a family trust on July 24, 2026, according to a regulatory disclosure filed with the Securities and Exchange Commission on July 28, 2026. …
Kenneth L. Daniels, a director of United Community Banks Inc. (NYSE: UCB), transferred 2,526 shares of common stock on July 24, 2026, to a revocable family trust for which he serves as trustee. The transaction, disclosed in a regulatory filing dated July 28, 2026, …
ORIC Pharmaceuticals, Inc. disclosed that Richard A. Heyman, a director of the company, completed multiple transactions involving the company's common stock on July 24, 2026. The transactions included both an acquisition and sales of shares, along with the exercise of stock options. The filing …
Sneha S. Shah, Executive Vice President and Chief AI Strategist at SEI Investments Co. (NASDAQ: SEIC), disclosed a sale of 3,746 shares of common stock on July 24, 2026, at a price of $96.73 per share. The transaction, filed with the Securities and Exchange …